Literature DB >> 8027315

Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.

M Yutsudo1, T Tanigaki, R Kanda, T Sasagawa, T Inoue, P Jing, H Yong-Il, A Hakura.   

Abstract

The involvement of human papillomavirus (HPV) in skin carcinogenesis in a patient with epidermodysplasia verruciformis was studied. This patient had disseminated pityriasis versicolor-like lesions, flat warts, and a malignant skin carcinoma. HPV types 3, 17, 20 (HPV-20), and 38 were isolated and molecularly cloned from the benign skin lesions of this patient. Of these HPVs, only HPV-20 was detected in the malignant skin carcinoma. Transcripts of HPV-20 were also expressed in the carcinoma. These findings suggest that HPV-20 was involved in the skin carcinogenesis in this patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027315      PMCID: PMC267188          DOI: 10.1128/jcm.32.4.1076-1078.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Epidemiologic aspects of epidermodysplasia verruciformis (L-L 1922) in Japan.

Authors:  T Tanigaki; R Kanda; M Yutsudo; A Hakura
Journal:  Jpn J Cancer Res       Date:  1986-09

2.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.

Authors:  A Mincheva; L Gissmann; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types.

Authors:  H Pfister; A Gassenmaier; F Nürnberger; G Stüttgen
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

4.  Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.

Authors:  A Hiraiwa; T Kiyono; K Segawa; K R Utsumi; M Ohashi; M Ishibashi
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

5.  Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis.

Authors:  R S Ostrow; M Bender; M Niimura; T Seki; M Kawashima; F Pass; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Human papillomavirus type 17 DNA in skin carcinoma tissue of a patient with epidermodysplasia verruciformis.

Authors:  M Yutsudo; T Shimakage; A Hakura
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

7.  Tumorigenic transformation of primary rat embryonal fibroblasts by human papillomavirus type 8 E7 gene in collaboration with the activated H-ras gene.

Authors:  T Nishikawa; T Yamashita; T Yamada; H Kobayashi; A Ohkawara; K Fujinaga
Journal:  Jpn J Cancer Res       Date:  1991-12
  7 in total
  4 in total

1.  Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs.

Authors:  A Adachi; T Kiyono; Y Hayashi; M Ohashi; M Ishibashi
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

2.  Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.

Authors:  Keith R Loeb; Maryam M Asgari; Stephen E Hawes; Qinghua Feng; Joshua E Stern; Mingjun Jiang; Zsolt B Argenyi; Ethel-Michele de Villiers; Nancy B Kiviat
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

3.  Restriction of viral gene expression and replication prevents immortalization of human keratinocytes by a beta-human papillomavirus.

Authors:  Tina M Rehm; Elke Straub; Thomas Iftner; Frank Stubenrauch
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-07       Impact factor: 12.779

4.  Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.

Authors:  Karin J Purdie; Thirunavukarasu Surentheran; Jane C Sterling; Louise Bell; Jane M McGregor; Charlotte M Proby; Catherine A Harwood; Judith Breuer
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.